A guide to antigen processing and presentation

被引:244
|
作者
Pishesha, Novalia [1 ,2 ,3 ]
Harmand, Thibault J. [1 ]
Ploegh, Hidde L. [1 ]
机构
[1] Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA
[2] Harvard Univ, Cambridge, MA 02138 USA
[3] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA
关键词
MHC CLASS-I; NATURAL-KILLER-CELLS; CROSS-PRESENTATION; PEPTIDE BINDING; HUMAN CYTOMEGALOVIRUS; EXOGENOUS ANTIGENS; CRYSTAL-STRUCTURE; HLA-E; MOLECULES; COMPLEX;
D O I
10.1038/s41577-022-00707-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This 'guide to' article provides an overview of the antigen processing and presentation pathways, which lead to the loading of antigenic peptides on major histocompatibility complex (MHC) molecules for detection by T cells. Antigen processing and presentation are the cornerstones of adaptive immunity. B cells cannot generate high-affinity antibodies without T cell help. CD4(+) T cells, which provide such help, use antigen-specific receptors that recognize major histocompatibility complex (MHC) molecules in complex with peptide cargo. Similarly, eradication of virus-infected cells often depends on cytotoxic CD8(+) T cells, which rely on the recognition of peptide-MHC complexes for their action. The two major classes of glycoproteins entrusted with antigen presentation are the MHC class I and class II molecules, which present antigenic peptides to CD8(+) T cells and CD4(+) T cells, respectively. This Review describes the essentials of antigen processing and presentation. These pathways are divided into six discrete steps that allow a comparison of the various means by which antigens destined for presentation are acquired and how the source proteins for these antigens are tagged for degradation, destroyed and ultimately displayed as peptides in complex with MHC molecules for T cell recognition.
引用
收藏
页码:751 / 764
页数:14
相关论文
共 50 条
  • [1] A guide to antigen processing and presentation
    Novalia Pishesha
    Thibault J. Harmand
    Hidde L. Ploegh
    [J]. Nature Reviews Immunology, 2022, 22 : 751 - 764
  • [2] Antigen processing and presentation
    Cresswell, P
    [J]. IMMUNOLOGICAL REVIEWS, 2005, 207 : 5 - 7
  • [3] Antigen processing and presentation
    Brodsky, FM
    Lem, L
    Bresnahan, PA
    [J]. TISSUE ANTIGENS, 1996, 47 (06): : 464 - 471
  • [4] Antigen processing and presentation
    Kotsias, Fiorella
    Cebrian, Ignacio
    Alloatti, Andres
    [J]. IMMUNOBIOLOGY OF DENDRITIC CELLS, PT A, 2019, 348 : 69 - 121
  • [5] ANTIGEN PROCESSING AND PRESENTATION
    GREY, H
    [J]. ANIMAL GENETICS, 1988, 19 : 68 - 69
  • [6] Antigen processing and presentation
    Larkin, DFP
    [J]. CICATRISING CONJUNCTIVITIS, 1997, 28 : 127 - 134
  • [7] ANTIGEN PROCESSING AND PRESENTATION
    TAKAHASHI, H
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 1993, 37 (01) : 1 - 9
  • [8] ANTIGEN PROCESSING AND PRESENTATION
    OTTEN, G
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1989, 2 (02) : 204 - 209
  • [9] ANTIGEN PROCESSING AND PRESENTATION
    GERMAIN, RN
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) : 769 - 776
  • [10] ANTIGEN PROCESSING AND PRESENTATION
    CORRADIN, G
    [J]. IMMUNOLOGY LETTERS, 1990, 25 (1-3) : 11 - 14